Filing metadata

Accession number
0001415889-22-008985
Form type
Form 4
Filer
Theravance Biopharma, Inc.
CIK
CIK 1583107
Filed
Aug 23, 2022
Reporting period
Aug 19, 2022
Description
Insider transaction

Explore SEC Filings Hub